Engineering a nano-drug delivery system to regulate m6A modification and enhance immunotherapy in gastric cancer
Zhengshuo Li(Central South University), Qun Yan(Central South University), Lingyu Wei(East China University of Science and Technology), Chenxiao Xu(Central South University), Run Zheng(Central South University), Yangge Wu(Central South University), Xiang Zheng, Xiaoyue Zhang(Wuhan University of Science and Technology), Can Liu(Fujian Medical University), Jiafu Wang, Peng Qiu, Junrui Tian(Central South University), Yuqing Wen(Central South University)
Cited by 20
Related Papers
CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling
|Journal of Experimental & Clinical Cancer Research|2020|152
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway
|Journal of Innate Immunity|2017|122
MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer
|Cancer Letters|2017|120
Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs
|Acta Biomaterialia|2017|116
Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer
|Cell Death and Disease|2022|110